fbpx Skip to main content

Biocom California Board of Directors

Meet the Board

Meet the Biocom California Board of Directors, working to ensure Biocom California’s programs, initiatives, and strategies work to accelerate life science across California.

“It’s so rewarding to see the tremendous impact the board has on advancing Biocom’s key initiatives and, through that, invigorating the entire Southern California life science community.””
Carin Canale, CEO, Canale Communications
“As past Chairman and current Board member of Biocom, I am thrilled that this organization continues to have such an impactful role in building the Life Science industry in California and in doing so contributes in a big way to the innovation economy. On a personal note, I treasure the time I spend on this dedicated Board with so many passionate and innovative leaders of this great industry.”
Magda Marquet, Co-Chairman & Founder, Althea

Board of Directors

Richard Pascoe
Chair; CEO, Histogen
Richard Pascoe
Chair; CEO, Histogen
Carin Canale-Theakston
Vice Chair; CEO, Canale Communications
Carin Canale-Theakston
Vice Chair; CEO, Canale Communications
Christophe Schilling, Ph.D.
Chair Emeritus; CEO, Genomatica, Inc.
Christophe Schilling, Ph.D.
Chair Emeritus; CEO, Genomatica, Inc.
Lisa Haile, J.D., Ph.D.
Vice Chair and General Counsel; Partner & Global Life Science Sector Chair, DLA Piper
Lisa Haile, J.D., Ph.D.
Vice Chair and General Counsel; Partner & Global Life Science Sector Chair, DLA Piper
Dan Kleeburg
Treasurer; Partner, Ernst & Young LLP
Dan Kleeburg
Treasurer; Partner, Ernst & Young LLP
Stephen Ferruolo, J.D., Ph.D.
Secretary; Partner, Perkins Coie LLP
Stephen Ferruolo, J.D., Ph.D.
Secretary; Partner, Perkins Coie LLP
Timothy Scott
Chair Elect; CEO, TEGA Therapeutics
Timothy Scott
Chair Elect; CEO, TEGA Therapeutics
Sabrina Martucci Johnson
Vice Chair of Industry; President and CEO, Daré Biosciences
Sabrina Martucci Johnson
Vice Chair of Industry; President and CEO, Daré Biosciences
Bernard Parker
Vice Chair, DE&I; Managing Partner, Caligen Bio LLC
Bernard Parker
Vice Chair, DE&I; Managing Partner, Caligen Bio LLC
Joseph Panetta
President and Chief Executive Officer, Member, Biocom Board of Directors
Joseph Panetta
President and Chief Executive Officer, Member, Biocom Board of Directors — San Diego

As the leading advocate for the life science industry in California, President and CEO Joe Panetta guides Biocom by setting strategic direction, guiding policy priorities, and championing the biopharmaceutical industry at the local, state, national, and international level.

Mr. Panetta holds a Bachelor of Science degree in biology from LeMoyne College, and a Master of Public Health degree in industrial and environmental health from the University of Pittsburgh. He is a graduate of the Brookings Institution Program for Executives and the Harvard Program on Negotiation.

 

Personal Interests:

  • Travel
  • Skiing
  • Piano
Ranjeet Banerjee
CEO, Cold Chain Technologies
Ranjeet Banerjee
CEO, Cold Chain Technologies
Dan Burgess
Chairman, Nabriva Therapeutics, PLC
Dan Burgess
Chairman, Nabriva Therapeutics, PLC
Jennifer Giottonini Cayer
Chairman of the Board of Directors,UCSD Cancer Center
Jennifer Giottonini Cayer
Chairman of the Board of Directors,UCSD Cancer Center
Chuck Dadswell, J.D.
Sr. VP & General Counsel, Illumina
Chuck Dadswell, J.D.
Sr. VP & General Counsel, Illumina
Eric Dube, Ph.D
President, CEO, Director at Travere Therapeutics.
Eric Dube, Ph.D
President, CEO, Director at Travere Therapeutics.
Wain Fishburn
Partner, Cooley
Wain Fishburn
Partner, Cooley
Enoch Kariuki, PharmD
CEO, Lengo Therapeutics
Enoch Kariuki, PharmD
CEO, Lengo Therapeutics
Magda Marquet, Ph.D.
Co-Founder & Co-CEO, ALMA Life Sciences, LLC
Magda Marquet, Ph.D.
Co-Founder & Co-CEO, ALMA Life Sciences, LLC
Paul Mola
President, CEO & Founder, Roswell Biotechnologies
Paul Mola
President, CEO & Founder, Roswell Biotechnologies
Steve Pacelli
EVP, Strategy & Corporate Affairs, DexCom
Steve Pacelli
EVP, Strategy & Corporate Affairs, DexCom
Trindl Reeves
Chief Sales Officer, Marsh & McLennan Agency
Trindl Reeves
Chief Sales Officer, Marsh & McLennan Agency
Peter Silvester
Senior Vice President, President of Life Sciences Solutions, Thermo Fisher Scientific
Peter Silvester
Senior Vice President, President of Life Sciences Solutions, Thermo Fisher Scientific
Larry Stambaugh
Chairman, Molecular Assemblies, Inc.
Larry Stambaugh
Chairman, Molecular Assemblies, Inc.

Board of Governors

Matt Abernethy
CFO, Neurocrine Biosciences
Matt Abernethy
CFO, Neurocrine Biosciences
Rick Bregman
San Diego Market President and National Co-Head of Bank of America’s Healthcare Banking Group
Rick Bregman
San Diego Market President and National Co-Head of Bank of America’s Healthcare Banking Group
Matthew Bresnahan, J.D.
Partner, Wilson Sonsini
Matthew Bresnahan, J.D.
Partner, Wilson Sonsini
Sandra Brown, Ph.D.
Vice Chancellor for Research, UCSD
Sandra Brown, Ph.D.
Vice Chancellor for Research, UCSD
Mark Cafferty
President & CEO, SD Regional Economic Development Corp.
Mark Cafferty
President & CEO, SD Regional Economic Development Corp.
Deanne Calvert, J.D.
Vice President, State Government Affairs, Sanofi Genzyme, US
Deanne Calvert, J.D.
Vice President, State Government Affairs, Sanofi Genzyme, US
Ho Cho, Ph.D.
Vice President, Biotherapeutics, Bristol Myers Squibb
Ho Cho, Ph.D.
Vice President, Biotherapeutics, Bristol Myers Squibb
Sunita Cooke, Ph.D.
Superintendent/President, Mira Costa College
Sunita Cooke, Ph.D.
Superintendent/President, Mira Costa College
Bassil Dahiyat, PhD.
President and CEO, Xencor
Bassil Dahiyat, PhD.
President and CEO, Xencor
DeeDee DeMan
Founder, Chairman & CEO, Bench International
DeeDee DeMan
Founder, Chairman & CEO, Bench International
Thierry Diagana, Ph.D.
Site Head, Emeryville Novartis Institutes for Biomedical Research
Thierry Diagana, Ph.D.
Site Head, Emeryville Novartis Institutes for Biomedical Research
Emad Fareed
Partner, KPMG, Inc
Emad Fareed
Partner, KPMG, Inc
Michael Farrington
Vice President Global Marketing, NuVasive
Michael Farrington
Vice President Global Marketing, NuVasive
Oliver Fetzer, Ph.D.
CEO, Synthetic Genomics
Oliver Fetzer, Ph.D.
CEO, Synthetic Genomics
Jack Florio
Managing Director, Objective Capital Partners
Jack Florio
Managing Director, Objective Capital Partners
Gregory Frost, Ph.D.
Chairman & CEO, EXUMA Biotech
Gregory Frost, Ph.D.
Chairman & CEO, EXUMA Biotech
Michael Garrison, Ph.D.
Worldwide President, Medication Management Solutions, BD Medical
Michael Garrison, Ph.D.
Worldwide President, Medication Management Solutions, BD Medical
Julie Gilmore, Ph. D.
Site Head and Chief Operating Officer, Lilly Gateway Labs
Julie Gilmore, Ph. D.
Site Head and Chief Operating Officer, Lilly Gateway Labs
Jeffrey W. Guise Ph.D. Esq.
Partner, Eversheds Sutherland
Jeffrey W. Guise Ph.D. Esq.
Partner, Eversheds Sutherland
Ronnie Hanecak, Ph.D.
Senior Director, Licensing, UCI Beall Applied Innovation
Ronnie Hanecak, Ph.D.
Senior Director, Licensing, UCI Beall Applied Innovation
Rachel Haurwitz, Ph.D.
President and CEO, Caribou Biosciences
Rachel Haurwitz, Ph.D.
President and CEO, Caribou Biosciences

Rachel is a co-founder of Caribou Biosciences and has been President and CEO since its inception in 2011. In 2014, she was named by Forbes Magazine to the “30 Under 30” list in Science and Healthcare, and in 2016, Fortune Magazine named her to the “40 Under 40” list of the most influential young people in business. In 2018, the Association for Women in Science recognized Rachel with the annual Next Generation Award. Rachel is an inventor on several patents and patent applications covering multiple CRISPR-based technologies, and she has co-authored scientific papers in high impact journals characterizing CRISPR-Cas systems. Rachel earned an A.B. in Biological Sciences from Harvard College, and received a Ph.D. in Molecular and Cell Biology from the University of California, Berkeley.

Richard Heyman, Ph.D.
Executive Chairman, Metacrine
Richard Heyman, Ph.D.
Executive Chairman, Metacrine
Natalie Hosea, Ph.D.
Site Head & Head of DMPK in San Diego, Takeda California
Natalie Hosea, Ph.D.
Site Head & Head of DMPK in San Diego, Takeda California
Ted Jacobs
Vice Chairman, CBRE
Ted Jacobs
Vice Chairman, CBRE
Steve Kay, Ph.D.
Provost Professor of Neurology, Biomedical Engineering and Biological Sciences Director of Convergent Bioscience, USC
Steve Kay, Ph.D.
Provost Professor of Neurology, Biomedical Engineering and Biological Sciences Director of Convergent Bioscience, USC
Paul Laikind, Ph.D.
Biocom Board Member
Paul Laikind, Ph.D.
Biocom Board Member
Cheston Larson, J.D.
Partner & Co-Chair Ð Life Sciences Industry Group, Latham & Watkins LLP
Cheston Larson, J.D.
Partner & Co-Chair Ð Life Sciences Industry Group, Latham & Watkins LLP
Scott Lippman, M.D.
Director, UCSD Moores Cancer Center
Scott Lippman, M.D.
Director, UCSD Moores Cancer Center
Andrew Lukowiak, Ph.D.
CEO, Millennium Health
Andrew Lukowiak, Ph.D.
CEO, Millennium Health
James Mackay, Ph.D.
CEO, Aristea Therapeutics
James Mackay, Ph.D.
CEO, Aristea Therapeutics
Stanley Maloy, Ph.D.
Associate Vice President for Research & Innovation, SDSU
Stanley Maloy, Ph.D.
Associate Vice President for Research & Innovation, SDSU
Damien McDevitt, Ph.D.
CEO, Aspen Therapeutics
Damien McDevitt, Ph.D.
CEO, Aspen Therapeutics
Juli Moran
San Diego Office Managing Partner & Managing Director, Deloitte Consulting LLP
Juli Moran
San Diego Office Managing Partner & Managing Director, Deloitte Consulting LLP
Marc T. Morley, J.D.
Member, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo
Marc T. Morley, J.D.
Member, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo
Bob Ramos, J.D.
Partner, Procopio
Bob Ramos, J.D.
Partner, Procopio
Daniel J. Ryan
Executive Vice President, Alexandria Real Estate Equities
Daniel J. Ryan
Executive Vice President, Alexandria Real Estate Equities
Tsuneo Takahashi
President, NF Corporation
Tsuneo Takahashi
President, NF Corporation
Olivier Toury
Co-Founder & CEO, Neuroservices-Alliance
Olivier Toury
Co-Founder & CEO, Neuroservices-Alliance
Kevin Tremblay
Sr. Director, SD Market Leader, Biomed Realty
Kevin Tremblay
Sr. Director, SD Market Leader, Biomed Realty
Jens Vogel, Ph.D.
SVP, Global Head of Product Supply Biotech, Bayer
Jens Vogel, Ph.D.
SVP, Global Head of Product Supply Biotech, Bayer
David Webb, Ph.D.
CEO, Synbal, Inc.
David Webb, Ph.D.
CEO, Synbal, Inc.
Tamera Weisser, Ph.D., J.D.
Intellectual Property Partner, Jones Day
Tamera Weisser, Ph.D., J.D.
Intellectual Property Partner, Jones Day

Emeritus Members

Ken Baldwin
Biocom Board Member
Ken Baldwin
Biocom Board Member
John Dunn
General Counsel, Vital Therapies
John Dunn
General Counsel, Vital Therapies
David Hale
Chairman, Hale BioPharma Ventures
David Hale
Chairman, Hale BioPharma Ventures
Guy Iannuzzi
CEO, Mentus
Guy Iannuzzi
CEO, Mentus
Brent Jacobs
Biocom Board Member
Brent Jacobs
Biocom Board Member
Jack Lief
Director, CeleCor
Jack Lief
Director, CeleCor
Steven Mento
Serial Entrepreneur
Steven Mento
Serial Entrepreneur
Tina Nova, Ph.D.
President and CEO, Decipher Biosciences
Tina Nova, Ph.D.
President and CEO, Decipher Biosciences